Open House - MSJ Program in Health, Science & Technology Law at Seton Hall Law

February 12, 2012 by Michael Ricciardelli · Leave a Comment
Filed under: Health Care Employment, Health Law

The next MSJ Open House will be on Saturday, February 25, 2012, from 9 a.m. until 11:30 a.m. (registration begins at 8:30 a.m.). Advanced registration is required. Register here >>

MSJ Program in Health, Science & Technology Law

Seton Hall Law School offers a Master of Science in Jurisprudence (MSJ) degree in Health, Science & Technology Law. The MSJ program provides professionals working in health care, information technology, telecommunication, pharmaceuticals and biotechnology with a solid foundation in the legal and regulatory aspects of these industries.

The MSJ is unique in that it provides a rigorous grounding in the law for students who do not want to become lawyers, but who, instead, want to use the law to enhance their effectiveness and marketability in a non-legal career. Combining this degree with their professional experiences, MSJ graduates have numerous opportunities available to them. Alumni work in a broad spectrum of positions as compliance officers, contract analysts, healthcare administrators, nurse managers, patent/trademark assistants, pharmaceutical financial analysts, quality assurance managers, supervisors, clinical operations directors, and lobbyists.

The MSJ Open House is an excellent opportunity for prospective applicants to meet and speak with faculty, students and administrators in a half-day long structured program.

The event will include an overview of the MSJ admissions process, the MSJ curriculum and course offerings, a question & answer session with the Director of the MSJ program, two mock classes led by current health law and intellectual property law faculty, information on financial aid, and tours of the law school. A relaxed lunch will allow for time to ask questions of special interest to you.

Please register for the Open House online or by contacting Helen A. Cummings, Administrator of Graduate Programs, at helen.cummings@shu.edu or 973-642-8380. Thank you for your interest in Seton Hall Law School’s MSJ program.

For more information on the MSJ Program as well as FAQs and Admissions criteria, click here.
For more information on the Open House, including a schedule, click here.

Tags: Center for Health and Pharmaceutical Law & Policy, Health Care Reform, Health Economics, Health Law, Health Policy Community, Health Reform, Health Science & Technology Law, Master of Science in Jurisprudence, MSJ

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!

Recent Posts

First Circuit Finds Generic Drugmaker Had State Law Duty to Stop Selling Unsafe Drug

Benefit Concert for Africa Surgery in Morristown, NJ

Lower Cost, But at What Cost?

Models of Patient Safety

Tara Ragone on Medical Loss Ratio Rebates in New Jersey

Recommended Reading: The FDA on Its Post-2007 Safety Ramp-Up and Barbara Evans on the Ethics of FDA-Mandated Postmarketing Studies

CIAs: OIG’s Favorite Enforcement Tool

Risperdal: Low Hanging Fruit for States with Medicaid Deficits?

Rigid, Severe Penalties of FCAs On Full Display

Professor Ani Satz on ‘Making Health and Disability Law More Responsive to Lived Experience’

At Last, HHS Releases the Affordable Health Insurance Exchanges Rule

EMTALA and the Free Rider Problem

Recommended Reading

Why Defeating the Individual Mandate isn’t Much of a Victory for Individual Freedom

Risky Business

No mandate? OK, but be prepared to pay

Why Can’t We Analogize the Mandate?

Day 2, The Individual Mandate: Justice Kennedy Swings Again

Supreme Court ACA Hearings, Day One

U.S. Supreme Court Health Reform Litigation, the Individual Mandate, Anti-Injunction Act, Commerce Clause and Even The Militia Act

Is a For-Profit Structure a Viable Alternative for Catholic Health Care Ministry?

Kate Greenwood on American Law Journal TV Regarding Off-Label Promotion

Ruane v. Levy: Both Sides of the Bar Meet in Health Care Fraud and Abuse Class

Trip Report, Sierra Leone, Tom Johnson, Jr., Africa Surgery, Inc. (ASI)

Must-Read Articles on Drug Shortages

A New Insurance Product: Responsible Corporate Officer Defense Insurance

Of Princes, Paupers, and Physicians

Making Health and Disability Law More Responsive to Lived Experience

AT&T and Intuitive Health Team Up to Bring Down Health Costs and Reduce Hospital Readmissions

Podcast: Distinguished Guest Practitioner Gian Luca Burci Lectures on the New Field of International Health Law

An Uncertain Future for ICD-10

Places Cited

Posts from Health Reform Watch have been cited by media sources throughout the country, including The New York Times, Washington Post, L.A. Times, Kaiser Health News, The Health Care Blog, NPR's Planet Money Blog, Duke Univ. Med. Center News, American Health Line Alerts, BusinessWeek.com, Concurring Opinions, Balkinization, The New England Journal of Medicine, Harvard's Nieman Foundation for Journalism, Las Vegas Sun, Maggie Mahar, Ezra Klein, Tom Geoghegan, and the official homepage of the Office of the Democratic Majority Leader of the House of Representatives, Steny Hoyer.
Recent Comments
Study Law Abroad
Audio Presentations

Click on the blue links to play, click again to pause:
Hatch-Waxman "Pay for Delay Audio: Panelists included Michael Kades, Attorney Advisor, Federal Trade Commission; Charles A. Gallia, Counsel, Gibbons P.C.; Anastasia Winslow, Assistant General Counsel, Bristol-Myers Squibb; and David Opderbeck, Associate Professor of Law and Director, Gibbons Institute of Law, Science & Technology.
Hunt Lecture: From the original post: During his week-long visit to Seton Hall Law School, Paul Hunt, Professor of Law, University of Essex School of Law, provided several lectures to students and faculty ...Read More
Maizel Lecture: From the original post: A noted expert in the restructuring of health care business debts, both in and out of court, Sam Maizel treated Seton Hall to a one hour crash course on the fiscal crisis ...Read More
PPACA Discussion: From the original post: On Friday, April 9th, Seton Hall was treated to an expert round table discussion on the new health reform measures. Visiting professor Tim Greaney ...Read More
Kaiser
The Commonwealth Fund
- Achieving Better Quality of Care for Low-Income Populations: The Role of Health Insurance and the Medical Home for Reducing Health Inequities
  A new analysis of the Commonwealth Fund 2010 Biennial Health Insurance Survey demonstrates that when low-income adults have both health insurance and a medical home, they are less likely to report cost-related access problems, more likely to be up-to-date with preventive screenings, and report greater satisfaction with the quality of their care.
- Recommended Core Measures for Evaluating the Patient-Centered Medical Home: Cost, Utilization, and Clinical Quality
  This Commonwealth Fund data brief describes how more than 70 researchers came together as part of the Patient-Centered Medical Home Evaluators’ Collaborative to identify a set of standardized measures to assess patient-centered medical homes.
- The World Health Report 2008—Primary Healthcare: How Wide Is the Gap Between Its Agenda and Implementation in 12 High-Income Health Systems?
  The authors of this Commonwealth Fund-supported study report on how the policy reforms set forth by the World Health Organization in 2008 are being implemented in 12 wealthy health systems.
- Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
  The authors of this Commonwealth Fund-supported study identified some steps that can be taken by the Guidelines International Network to ensure that guideline development processes "are both rigorous and feasible even for modestly funded groups to implement."
- Integrating Immigrants into the U.S. Health System
  The authors of this Commonwealth Fund-supported study argue that physicians must develop competencies to provide culturally sensitive care to a more diverse patient population.
RWJF Health Reform News
- GOP Shies Away from Offering Healthcare Reform Alternative
  Republicans might not offer a comprehensive plan to replace President Obama’s healthcare law if the Supreme Court strikes it down this summer.
- Study: Privately Insured Kids Get More Care in ED
  Emergency departments are required to treat everyone who comes through the doors, but that doesn’t mean they treat everyone the same way.
- Obesity, a New Kind of Smoke
  The war on smoking can help guide the nation’s fight against obesity. Trash food can be the cigarette.
- Have California Schools Cracked the Code on Obesity?
  When it comes to nutrition policy, we know about a lot of things that don’t work: Soda taxes and proximity to healthy foods, for example, have relatively shaky support in the public health literature.
- Type 2 Diabetes in Kids not Child’s Play
  If ever we needed a wake-up call on the state of American children’s health, consider the growing proliferation of Type 2 diabetes in our youth, as detailed in a study recently published in The New England Journal of Medicine.
ACA Litigation Blog
NY Times Health Policy
- F.D.A. Panel Backs Easier Home H.I.V. Test
  An advisory body recommended that the Food and Drug Administration approve the OraQuick test, which uses a mouth swab to give a result in 20 minutes.
- Romney Medicare Plan Draws Stark Contrast With Obama’s
  Mitt Romney says President Obama has no workable plan to prevent Medicare from going bankrupt, and that he is offering “a dramatic change in perspective and philosophy.”
- News Analysis: Taking Truvada to Prevent H.I.V. Also Comes With Risks
  Taking Truvada daily can help people in at-risk groups prevent H.I.V. infection, but the consequences of loose adherence go beyond contracting the virus.
- Whooping Cough Epidemic Hits Washington State
  Efforts in Washington State to address a resurgent childhood ailment have been hobbled by years of recession-induced budget cuts that have hollowed out public health departments.
- Economic View: Slippery-Slope Logic vs. Health Care Law - Economic View
  The court debate over the new health care law offers yet another example of worrying about imaginary risks.
WaPo Health
- President’s Council on Fitness backs Wii, Kinect and other video games
  We called it “the devil’s machine” in my house, and the Faustian bargain we struck over that first Nintendo 64 would have impressed Lucifer himself. We bought it for my son when he was perhaps 7; it provided countless hours of contentment for him and an equal measure of downtime for Mom and Dad. Read full article >>
- The struggles of D.C. area yoga studios
  The deal with yoga in Washington is getting kind of complicated. If it’s a bargain you’re after, that’s not hard to find, especially with DC Yoga Week starting Sunday. Now in its seventh year, the event is eight days of free and $5 classes at 24 studios across the area. (This year, Maryland and Virginia studios are taking part, too.) And any other wee […]
- Spin/yoga classes find balance of body and mind
  It seems as though we are always struggling for balance in our lives. Work or play? Spend or save? Eat that doughnut or save those calories? The same is true for our fitness regimens. Everyone from the Centers for Disease Control and Prevention to your physician wants you to mix cardiovascular workouts with strength training, stretching and balance drills. […]
- Alternative bachelorette parties: trapeze, ballet barre, ropes course and more
  The morning after 25-year-old Nicki Bonebrake’s bachelorette party two weeks ago, she could barely get out of bed. The problem wasn’t that the Gaithersburg resident had stayed out all night with her friends — although she had. It was that her body was still dealing with the fact that she’d spent the previous morning learning the art of flying trapez […]
- 5 so-called health foods you should avoid
  Eating healthy can be harder than you think, thanks to an enterprising food industry that wants us to consume more than we need. That’s because our country’s agricultural system produces twice what most people require, according to the U.S. Department of Agriculture’s Economic Research Service. This encourages creative marketing to unload the excess, […]
Fierce Healthcare
- Piramal bets on pharma's data binging in $635M buyout
  Sold on the growing need for market data in biopharma, India's Piramal Healthcare has scooped up Decision Resources Group in deal valued at about $635 million, Piramal and DRG revealed Wednesday. The deal comes amid rapid business expansion at Decision Resources, which provides web-based research tools, predictive analytics and other services to drugmak […]
- Cancer drug experts brace for ASCO abstract dump tonight
  Tonight's the big night for cancer drug watchers. ASCO is releasing a mountain of data on cancer studies, and some of the biggest names in the business will be angling for star billing on some closely watched therapies. Peter Loftus at Dow Jones lists Pfizer ($PFE), GlaxoSmithKline ($GSK) and Johnson & Johnson ($JNJ) among the big names that will b […]
- UPDATED: Upstart Ra sheds stealth status, targets new drug class
  Cambridge, MA-based Ra Pharmaceuticals is stealth no more. Two years after it snagged an initial $10 million in venture cash, Ra has hauled in a second tranche of $8.6 million and picked its disease target: hereditary angioedema, a rare and lethal immune system disorder. And after maintaining strict silence as the biotech was being incubated at Morgenthaler […]
- Achillion burnishes buyout prospects, snags fast track for hep C drug
  Achillion CEO Michael Kishbauch hasn't been the least bit shy about touting the company's buyout prospects. Quick to boast about the biotech's promising hepatitis C drugs, he's been raising hopes and stirring buyout buzz with every appearance. And today Kishbauch is sporting another feather in his cap: An FDA fast-track designation for a […]
- Elevation boasts 'gold standard' IIb data for COPD therapy
  Four months ago San Diego-based Elevation Pharmaceuticals unveiled a $30 million venture round as it mapped out plans to complete an ambitious mid-stage program for its COPD treatment. Today the biotech boasted that the therapy--EP-101--had registered positive data in a Phase IIb study, positioning it as a potential new "gold standard" in nebulized […]
- Genentech drug picked for pioneering $100M Alzheimer's trial
  The NIH has agreed to help bankroll a pioneering $100 million study of Genentech's experimental Alzheimer's therapy crenezumab. Investigators will test the drug in a region of Colombia where a particular genetic mutation is known to trigger the early onset of Alzheimer's, with an eye to determining if they can stop the memory-wasting ailment b […]
- Payers likely to throw up hurdles to Pfizer's new RA drug
  You know that old adage: The one with the gold makes the rules? For the latest exhibit, look no further than Pfizer's ($PFE) anticipated rheumatoid arthritis treatment tofacitinib. After an FDA advisory panel voted in favor of the drug last week, Reimbursement Intelligence surveyed 30 big payers, asking how they'd manage access to the new treatment […]
- First wave of AstraZeneca's CNS R&D group gets the ax
  AstraZeneca isn't wasting any time in pushing ahead with draconian cuts to its neuroscience work in its big R&D hub south of Stockholm. The first 50 scientists have already been shown the door, according to local news reports, part of the first wave of 400 job cuts as AstraZeneca ($AZN) slashes a total of 1,100 positions at the research complex. […]
- Newron soars on positive PhIII results, $26M pact for Parkinson's drug
  Despite being left at the M&A altar last fall after a key partnership deal collapsed, Newron says it has successfully completed two late-stage studies of its experimental Parkinson's drug. And the Italian biotech used the opportunity to announce that it has garnered a 20 million euro licensing deal with Zambon for the drug. At the same time, Newron […]
- Buzz: Big Pharma suitors line up for a look at Amylin's books
  One of the cardinal rules involved in deal-making focuses on the need to get as many buyers to the negotiating table as possible. The next big rule: Make sure everyone knows who's interested in bidding. Amylin--while maintaining a strict no comment policy ever since initial reports appeared the Bristol-Myers Squibb ($BMY) had made an offer--has scored o […]
Boston Globe Health Blog
- MIT professor wins prestigious chemistry prize
  By Carolyn Y. Johnson, Globe Staff Robert Langer, a biomedical engineer at MIT best known for his contributions in the fields of tissue engineering and drug delivery, has been named the winner of the 2012 Priestley Medal, a prestigious prize...
- Daily check up: New York Times points to Mass. public opinion on health care mandate as a model
  In an editorial today, the Times says support for the national mandate could follow the recent trend in Mass. and grow
- Brigham and Women's performs face transplant on woman mauled by chimp
  Jonathan Wiggs / Globe Staff Photo Steve Nash, brother of Charla Nash, who received a full face transplant at Brigham and Women's Hospital late last month, appeared at a press conference today with his wife, Kate. Charla Nash did not...
- Poll: Public supports mandatory physical education
  In a survey of 501 Mass. residents, 87 percent said the state should require 30 min. of physical activity each school day
- Immigrant health care back in court
  Immigrant advocates had hoped for a quick decision, but the state plans to file a motion that would delay the process
LA Times Health Blog
- Breast cancer study reveals 'substantial genetic diversity'
  A new study of the protein-coding genes in 100 breast cancer tumors revealed vast differences among the cancers and highlights how complicated the disease really is, researchers said Wednesday.
- Healthy food doesn't have to be expensive, USDA insists
  Healthy food, we’ve often heard, is pricey food. Fruits and vegetables -- they’re expensive! We can’t afford to eat that way! That’s why we don’t do it!
- Chain restaurants don't meet U.S. nutrition guidelines, study says
  Plenty of restaurants have been advertising their efforts to offer healthful choices, and it’s possible to eat carefully just about anywhere. But researchers say nearly all the entrees they reviewed at 245 U.S. chains fail to meet federal guidelines.
Health Affairs Blog
- Implementing Health Reform: State-Based, Partnership, And Federally Facilitated Exchanges
  On May 16, 2012, the Department of Health and Human Services moved three steps closer to the implementation of the Affordable Care Act’s health insurance exchanges, which will happen on January 1, 2014. First, HHS announced the award of 5 new level 1 exchange establishment grants (Illinois, Nevada, Oregon, South Dakota, and Tennessee) and one [...]
- Remembering Larry Lewin: A Legacy Of Accomplishment And Mentorship
  On April 29, 2012, four days after his 74th birthday, Larry Lewin (pictured below) died from complications of an underlying cancer. The funeral was May 1 and his wife, Marion asked me to speak briefly about his professional life. What follows is adapted from those remarks. It will be obvious that anyone who knew Larry [...]
- Electronic Prescribing: Where We Stand And Lessons For Policymakers
  Editor’s note: For more on the adoption of electronic health systems, see these recent Health Affairs articles by Decker and coauthors, DesRoches and coauthors, and Hsiao and coauthors, which were discussed at an April 25 event. Since the American Recovery and Reinvestment Act passed in 2009, healthcare professionals, researchers, analysts and policy m […]
- The Latest Health Wonk Review
  A belated tip of the hat to Hank Stern’s Health Wonk Review at Insure Blog. Hank offers a nice collection of posts, including Diane Meier’s Health Affairs Blog post on Amy Berman’s Narrative Matters essay and overcoming barriers to palliative care. Happy reading! �
- Early Lessons From A Shared Risk, Integrated Care Organization Serving A Commercial Population
  Background: The Centers for Medicare and Medicaid Services’ designation of 32 accountable care organizations (ACOs) across the U.S. to enroll Medicare fee-for-service patients beginning in 2012 makes ACOs an important feature of the national healthcare landscape–at least for publicly insured patients.However in 2007, Blue Shield of California, along wi […]

Center News, Programs & Papers

Making Health and Disability Law More Responsive to Lived Experience

Livestream Podcast, Seton Hall Law Review ACO Symposium

Symposium: Implementing the Affordable Care Act: What Role for Accountable Care Organizations?

Distinguished Guest Practitioner Mark Swearingen Lectures on Trends in Healthcare Law Enforcement

Online Graduate Certificate Program in Pharmaceutical & Medical Device Law to Begin in May 2011

New Jersey’s Commissioner of Health and Senior Services Discusses Medical Marijuana and Two Other Regulatory “Case Studies” at Seton Hall Law

The Limits of Disclosure as a Response to Finanacial Conflicts of Interest in Clinical Research

Fourth Annual Student Health Law Conference To Be Held at Seton Hall Law on October 22nd

Seton Hall University School of Law Launches European Healthcare Compliance Certification Programme in Paris

Seton Hall Law Announces Frank Pasquale as the Schering-Plough Professor in Health Care Regulation and Enforcement

Former UN Special Rapporteur Paul Hunt on International Law & Health as a Human Right & the Human Rights Responsibilities of Pharmaceutical Companies

Recording of Sam Maizel’s Discussion of Distressed Hospitals

Recording of Professors Tim Greaney, John Jacobi, Frank Pasquale, and Sidney Watson Discussing Health Reform

Seton Hall Announces Summer Study Abroad International Health Law Program

Online Graduate Certificate Program in Health & Hospital Law to Launch in April 2010

Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy Issues White Paper Calling for Major Reforms in the Financing and Oversight of Clinical Research

Risks to Directors and Trustees of Health Care & Life Sciences Companies: Corporate Compliance in a Distressed Economy

Third Annual Student Health Law Conference, Friday, October 16th at Seton Hall Law

Position Paper In Support of the “New Jersey Compassionate Use Medical Marijuana Act”

Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy Releases White Paper Recommending Reform of Drug and Device Promotion

Tags
ACA Accountable Care Organizations ACO Center for Health and Pharmaceutical Law & Policy Chronic Conditions CMS Conflicts of Interest Constitutional Cost Control Drug & Device Drug and Device Electronic Medical Records EMR FDA Fraud and Abuse Health Care Health Care Reform Health Economics Health Law Health Policy Community Health Reform HHS Hospital Finances Individual Mandate Medicaid Medical Malpractice Medicare National Newspapers & Media Obama Administration Pharma pharmaceutical industry Physician Compensation PPACA Prescription Drugs Private Insurance Proposed Legislation Public Health Public Option Public Plan Quality Improvement Seton Hall Law State Initiatives Think Tanks Unconstitutional Uninsured
Meta

HEALTH REFORM WATCH

Open House - MSJ Program in Health, Science & Technology Law at Seton Hall Law

MSJ Program in Health, Science & Technology Law

Speak Your Mind

Recent Posts

Categories

Health Reform Law (PPACA) Complete Text

News Sources

Noteworthy Blogs

Of Interest

Resources

Wordpress

Places Cited

Recent Comments

Study Law Abroad

Audio Presentations

Kaiser

The Commonwealth Fund

RWJF Health Reform News

ACA Litigation Blog

NY Times Health Policy

WaPo Health

Fierce Healthcare

Boston Globe Health Blog

LA Times Health Blog

Health Affairs Blog

Center News, Programs & Papers

Meta